Kismet is a technology company.
Kismet has raised $11.8M across 3 funding rounds.
Kismet has raised $11.8M in total across 3 funding rounds.
Kismet has raised $11.8M in total across 3 funding rounds.
Kismet's investors include Airtree Ventures, Jenny Fielding, Scott Hartley, AngelPad, BITKRAFT Ventures, BoxGroup, ENIAC Ventures, Great Oaks Venture Capital, Notion Capital, Pro Founders Capital, Shine Capital, Slow Ventures.
Kismet Technologies is a woman-owned R&D company specializing in innovative nanotechnology for antimicrobial protection, primarily through its flagship product NanoRAD—a transparent disinfectant coating that generates on-demand hydrogen peroxide to combat viruses, bacteria, and pathogens.[1][2][4][5] Founded in 2019, it serves healthcare, medical devices, consumer products, and industrial sectors by addressing infection control challenges with eco-friendly solutions that reduce chemical use and environmental waste, while pursuing FDA and EPA approvals for broader applications like hospitals, cruise ships, and clean rooms.[1][2][4] With 7 employees and recent growth including a $0.5M grant in 2024, the company is scaling via a new Orlando manufacturing facility and pilot programs, backed by non-dilutive funding from the National Science Foundation and partnerships like UCF Business Incubation.[2][3]
Kismet Technologies was founded in 2019 by Christina Drake, who aimed to commercialize NanoRAD, a nanotechnology initially developed for viral disinfection.[2] Drake, leveraging persistence as her key driver, expanded the portfolio to infection-control products for wound healing and medical device coatings.[1][2] Early traction came from UCF Business Incubation Program support, Cenfluence resources for competitions and events, and 2020 STTR funding from the National Science Foundation, which enabled proof-of-concept work with UCF researchers.[2] This built confidence for further grants from Florida Opportunity Fund, MassChallenge, and others, propelling the company toward manufacturing and regulatory milestones.[3]
Kismet rides the wave of post-pandemic infection prevention and rising demand for sustainable antimicrobials amid antimicrobial resistance and climate-conscious materials.[1][2] Timing aligns with healthcare's push for reduced chemical disinfectants and EPA/FDA scrutiny on green tech, amplified by global events like COVID-19 that highlighted pathogen spread in shared spaces.[2][4] Market forces favor it: growing biotech/pharma needs for device coatings, plus industrial shifts to low-waste solutions in paints and consumer goods.[3][5] By influencing ecosystems through UCF incubation and NSF-backed R&D, Kismet accelerates nanotechnology adoption, lowering infection rates in healthcare and beyond while enabling partners to launch "next-gen" branded products.[2][5]
Kismet Technologies is poised for expansion with its Orlando facility, hospital pilots, and regulatory approvals unlocking markets in healthcare and beyond.[2] Trends like AI-driven material science and stricter EPA rules on sustainability will boost its chitosan/cerium tech, potentially driving partnerships in consumer goods and medtech.[5] Its influence may grow as a nanotechnology leader in infection control, evolving from R&D startup to scalable manufacturer—transforming safer lives with minimal planetary impact, as envisioned from its founding.[1]
Kismet has raised $11.8M across 3 funding rounds. Most recently, it raised $8.0M Seed in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $8.0M Seed | Airtree Ventures, Jenny Fielding, Scott Hartley | |
| May 1, 2023 | $3.0M Seed | Airtree Ventures, Jenny Fielding, Scott Hartley | |
| Feb 1, 2011 | $770K Seed | AngelPad, BITKRAFT Ventures, BoxGroup, ENIAC Ventures, Great Oaks Venture Capital, Notion Capital, Pro Founders Capital, Shine Capital, Slow Ventures, The Finger Group, Weekend Fund, Y Combinator, Ben Lin, Eben Pagan, Scott Belsky |